Could the dodo return? US firm maps 95% of its genome and identifies gene-editing targets
Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies.
By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits.
With 95% of the dodo genome analysis complete, their ambitious project is on track, though a specific timeline for the living dodo remains undisclosed.
This groundbreaking venture is part of a larger initiative to counteract the effects of human-induced species extinction.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on timesofindia.indiatimes.com — the content belongs to Times of India - World.
